Haji Chalchal
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 26
- Pancreatic and Hepatic Oncology Research 7
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 4
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Lois E. Shepherd (7 shared papers)Dongsheng Tu (4 shared papers)Derek J. Jonker (3 shared papers)Heather‐Jane Au (1 shared paper)Niall C. Tebbutt (1 shared paper)John Zalcberg (1 shared paper)Timothy Price (1 shared paper)Jeremy Shapiro (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Cancers (4 papers)Annals of Oncology (3 papers)Clinical Colorectal Cancer (2 papers)Pancreas (2 papers)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
Haji Chalchal
46 papers receiving 3.6k citations
Haji Chalchal's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 2.2k
- Cancer Research 694
- Pathology and Forensic Medicine 794
- Hepatology 262
- Pulmonary and Respiratory Medicine 705
Countries citing papers authored by Haji Chalchal
This map shows the geographic impact of Haji Chalchal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haji Chalchal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haji Chalchal more than expected).
Fields of papers citing papers by Haji Chalchal
This network shows the impact of papers produced by Haji Chalchal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haji Chalchal. The network helps show where Haji Chalchal may publish in the future.
Co-authors
The 25 scholars most cited alongside Haji Chalchal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer Hit paper breakdown → | 2008 | 2775 |
| 2 | 2005 | 148 | |
| 3 | 2009 | 113 | |
| 4 | 2010 | 101 | |
| 5 | 2015 | 97 | |
| 6 | 2015 | 93 | |
| 7 | 2018 | 49 | |
| 8 | 2014 | 41 | |
| 9 | 2016 | 35 | |
| 10 | 2019 | 28 | |
| 11 | 2012 | 27 | |
| 12 | 2017 | 20 | |
| 13 | 2007 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2015 | 15 | |
| 16 | 2022 | 11 | |
| 17 | 2001 | 11 | |
| 18 | 2002 | 11 | |
| 19 | 2001 | 10 | |
| 20 | 2019 | 9 |
About Haji Chalchal
Haji Chalchal is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Genetics, having authored 48 papers that have together received 3.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Breast Cancer Treatment Studies (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (4 papers) and Economic and Financial Impacts of Cancer (3 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (694 citations), Pathology and Forensic Medicine (794 citations), Hepatology (262 citations) and Pulmonary and Respiratory Medicine (705 citations). Haji Chalchal has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Lois E. Shepherd, Dongsheng Tu, Derek J. Jonker, Heather‐Jane Au, Niall C. Tebbutt, John Zalcberg, Timothy Price, Jeremy Shapiro, Malcolm J. Moore and Christos S. Karapetis. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Annals of Oncology, Clinical Colorectal Cancer and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.